Cost-effectiveness of bazedoxifene compared with raloxifene in the treatment of postmenopausal osteoporotic women

Meta-analysis: Excess Mortality After Hip Fracture Among Older Women and Men

(2013) Patrick Haentjens   ANNALS OF INTERNAL MEDICINE

Long-term death and recurrence in patients with acute venous thromboembolism: The MASTER registry

(2012) Melina Verso et al.   THROMBOSIS RESEARCH

The Clinical and Economic Burden of Poor Adherence and Persistence with Osteoporosis Medications in Ireland

(2012) Mickaël Hiligsmann et al.   VALUE IN HEALTH

Trends in hip fracture incidence and in the prescription of antiosteoporosis medications during the same time period in Belgium (2000-2007)

(2012) Mickaël Hiligsmann et al.   ARTHRITIS CARE & RESEARCH

The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis

(2012) Mickaël Hiligsmann et al.   Expert Review of Pharmacoeconomics & Outcomes Research

Partial adherence: a new perspective on health economic assessment in osteoporosis

(2011) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Cost Effectiveness of Denosumab Compared with Oral Bisphosphonates in the Treatment of Post-Menopausal Osteoporotic Women in Belgium

(2011) Mickaël Hiligsmann et al.   PHARMACOECONOMICS

Potential cost-effectiveness of denosumab for the treatment of postmenopausal osteoporotic women

(2010) Mickaël Hiligsmann et al.   BONE

Identifying cost-effective treatment with raloxifene in postmenopausal women using risk algorithms for fractures and invasive breast cancer

(2010) M. Ivergård et al.   BONE

FRAX® and its applications in health economics—Cost-effectiveness and intervention thresholds using bazedoxifene in a Swedish setting as an example

(2010) O. Ström et al.   BONE

Potential Clinical and Economic Impact of Nonadherence with Osteoporosis Medications

(2010) Mickaël Hiligsmann et al.   CALCIFIED TISSUE INTERNATIONAL

The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients

(2010) Mickaël Hiligsmann et al.   HEALTH POLICY

Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective

(2010) F. Borgström et al.   OSTEOPOROSIS INTERNATIONAL

A FRAX® model for the assessment of fracture probability in Belgium

(2010) H. Johansson et al.   OSTEOPOROSIS INTERNATIONAL

Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis

(2010) B. Jönsson et al.   OSTEOPOROSIS INTERNATIONAL

Cost–Effectiveness of Osteoporosis Screening Followed by Treatment: The Impact of Medication Adherence

(2010) Mickaël Hiligsmann et al.   VALUE IN HEALTH

Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX®

(2009) John A. Kanis et al.   BONE

Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75 years

(2009) Mickaël Hiligsmann et al.   BONE

Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic women

(2009) M. Hiligsmann et al.   OSTEOPOROSIS INTERNATIONAL

Development and Validation of a Markov Microsimulation Model for the Economic Evaluation of Treatments in Osteoporosis

(2009) Mickaël Hiligsmann et al.   VALUE IN HEALTH

Utility Values Associated with Osteoporotic Fracture: A Systematic Review of the Literature

(2008) Mickaël Hiligsmann et al.   CALCIFIED TISSUE INTERNATIONAL

Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial*

(2008) Stuart L Silverman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Belgian Methodological Guidelines for Pharmacoeconomic Evaluations: Toward Standardization of Drug Reimbursement Requests

(2008) Irina Cleemput et al.   VALUE IN HEALTH